These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Smart biomaterials design for tissue engineering and regenerative medicine. Furth ME; Atala A; Van Dyke ME Biomaterials; 2007 Dec; 28(34):5068-73. PubMed ID: 17706763 [TBL] [Abstract][Full Text] [Related]
44. Biomaterial-mediated delivery of microenvironmental cues for repair and regeneration of articular cartilage. Toh WS; Spector M; Lee EH; Cao T Mol Pharm; 2011 Aug; 8(4):994-1001. PubMed ID: 21500855 [TBL] [Abstract][Full Text] [Related]
45. Tissue engineering using pluripotent stem cells: multidisciplinary approaches to accelerate bench-to-bedside transition. Hunt NC; Lako M Regen Med; 2016 Sep; 11(6):495-8. PubMed ID: 27484404 [No Abstract] [Full Text] [Related]
47. Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine. Hemshekhar M; Thushara RM; Chandranayaka S; Sherman LS; Kemparaju K; Girish KS Int J Biol Macromol; 2016 May; 86():917-28. PubMed ID: 26893053 [TBL] [Abstract][Full Text] [Related]
48. Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications. Gilpin A; Yang Y Biomed Res Int; 2017; 2017():9831534. PubMed ID: 28540307 [TBL] [Abstract][Full Text] [Related]
49. Lessons from (patho)physiological tissue stiffness and their implications for drug screening, drug delivery and regenerative medicine. Chen WL; Simmons CA Adv Drug Deliv Rev; 2011 Apr; 63(4-5):269-76. PubMed ID: 21241759 [TBL] [Abstract][Full Text] [Related]
51. Biologic scaffolds for regenerative medicine: mechanisms of in vivo remodeling. Londono R; Badylak SF Ann Biomed Eng; 2015 Mar; 43(3):577-92. PubMed ID: 25213186 [TBL] [Abstract][Full Text] [Related]
52. Cardiac Extracellular Matrix Modification as a Therapeutic Approach. Hall ML; Ogle BM Adv Exp Med Biol; 2018; 1098():131-150. PubMed ID: 30238369 [TBL] [Abstract][Full Text] [Related]
53. Decellularized matrices for tissue engineering. Hoshiba T; Lu H; Kawazoe N; Chen G Expert Opin Biol Ther; 2010 Dec; 10(12):1717-28. PubMed ID: 21058932 [TBL] [Abstract][Full Text] [Related]
54. Multiple facets for extracellular matrix mimicking in regenerative medicine. Zhang YS; Xia Y Nanomedicine (Lond); 2015; 10(5):689-92. PubMed ID: 25816873 [No Abstract] [Full Text] [Related]
55. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. Prestwich GD J Control Release; 2011 Oct; 155(2):193-9. PubMed ID: 21513749 [TBL] [Abstract][Full Text] [Related]
56. The application of decellularized human term fetal membranes in tissue engineering and regenerative medicine (TERM). Shakouri-Motlagh A; Khanabdali R; Heath DE; Kalionis B Placenta; 2017 Nov; 59():124-130. PubMed ID: 28693892 [TBL] [Abstract][Full Text] [Related]
57. [Research progress of decellularization and application in tissue engineering]. Zhao Y; Yu M; Bai S Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Aug; 27(8):950-4. PubMed ID: 24171349 [TBL] [Abstract][Full Text] [Related]